Amidst the growing concerns about the spread of the Ebola virus, a company in Japan is offering what could be the solution. A drug that has been widely used in Japan against the flu is also being used as an experimental Ebola treatment, and apparently it is expected to do a good job. Given the fatality rate of Ebola it comes as no surprise that doctors want to try anything they can to treat it.
The World Health Organization is hopeful that this drug will work against Ebola, but they say they’re not putting all their eggs in this one basket. If it does in fact work against Ebola it will only be a matter of time before it can be distributed as needed. In addition to experimental trials the company behind the product is also working to have it clinically tested and approved for human use against Ebola, so that in the future it can actually be used as a full force drug.
Whether or not this drug will work is yet to be seen, but many experts are hopeful that it might work. At this point any sign of hope is a good thing and doctors say this is the most promising step in the past few months. Experimental treatments are beginning soon so it is only a matter of time before we know if it is actually going to work.
The World Health Organization is hopeful that this drug will work against Ebola, but they say they’re not putting all their eggs in this one basket. If it does in fact work against Ebola it will only be a matter of time before it can be distributed as needed. In addition to experimental trials the company behind the product is also working to have it clinically tested and approved for human use against Ebola, so that in the future it can actually be used as a full force drug.
Whether or not this drug will work is yet to be seen, but many experts are hopeful that it might work. At this point any sign of hope is a good thing and doctors say this is the most promising step in the past few months. Experimental treatments are beginning soon so it is only a matter of time before we know if it is actually going to work.
No comments:
Post a Comment